US 9045494
Orthoester compound
granted A61KA61K31/74A61K9/1611
Quick answer
US patent 9045494 (Orthoester compound) held by Nektar Therapeutics expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 1
- CPC classes
- A61K, A61K31/74, A61K9/1611, A61K9/1617, A61K9/1623